Content provided by
Hi everyone, I’m Dr. Sanjeev Goel, and you’ll be listening to the “Advanced Anti-aging And Technology Summit.” Today, I’ll be interviewing Dr. Gordan Lauc. Gordan Lauc is a Professor of Biochemistry and Molecular Biology at the University of Zagreb. Director of the National Center of Scientific Excellence and Personalized Healthcare. Honorary Professor at the University of Edinburgh, and the Kings College London. And, member of the John Hopkins Society of Scholars. In 2017, he initiated the launch of “The Human Glycome Project” and he’s one of its two co-directors. His research team is pioneering high-throughput glycomic analysis, and application of glycan biomarkers in the field of precision medicine.
By combining glycomic data with extensive genetic epigenetic, biochemical, and physiological data, in a systems biology approach. They’re trying to understand the role of glycans in normal physiology and disease. Professor Lauc, has co-authored over 200 research articles that are cited over 5,000 times. In 2007, he founded Genos, a biotech company that is currently global leader in high-throughput glycomics. Research in Genos led to the development of the GlycanAge test of biologic age. I hope you enjoy today’s talk with Dr. Lauc. Okay, welcome Dr. Gordan Lauc. I really appreciate your time today, to talk about this whole new field of glycanomics. I’m not sure what the word is, but thank you. Thank you for taking the time all the way from Zagreb.